ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Northwest Biotherapeutics Inc (QB)

Northwest Biotherapeutics Inc (QB) (NWBO)

0.2676
-0.00098
( -0.36% )
Updated: 12:46:18

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

NWBO News

Official News Only

NWBO Discussion

View Posts
learningcurve2020 learningcurve2020 2 minutes ago
We know where their true executional talent lies. 
👍️0
underpar71 underpar71 4 minutes ago
Generally, there is no specific, dedicated time frame outlined in the Federal Rules of Civil Procedure for a defendant to respond to a Notice of Supplemental Authority filing; however, most courts would expect a response within a reasonable time, often following the same timeframe as responding to other motions, which could be around 14 to 21 days depending on local rules and the court's specific practices.
Key points to remember:
Check local rules:
Always consult the local rules of the court where the case is filed, as they may specify a specific time for responding to supplemental authority filings.
Reasonable time:
Even without a specific rule, courts generally expect a response within a reasonable time frame, allowing the opposing party to review the new authority and prepare a response if necessary.
Opposing party's response:
If a defendant feels the supplemental authority is irrelevant or improper, they can file a brief opposing the new legal arguments presented.
👍️0
flipper44 flipper44 6 minutes ago
Again, I think Market Makers had a responsibility to bring it to the Court’s attention as well. They haven’t, yet. That’s about all there is to say about that.
👍️0
Doc logic Doc logic 9 minutes ago
iclight,

That other product does not produce immune memory so has no way to work towards a cure and quality of life is an issue during constant use.
Wishing that folks were dead by ignoring their response to Direct even though the trial parameters and mode of action precluded “response rate” from forming is no way to go through life either. Your “response rate” is meaningless in this regard because of how this immunotherapy was working to create peseudoprigression and necrosis without the breakdown of large amounts of tumor tissue. Improving upon it and allowing treatment to continue past pseudoprogression will produce a more complete immune response as necrotic material is removed by other cells. Your narrative does not allow this to be mentioned because that would lead to more interest in what Direct is really all about. Your narrative will die soon and your moniker with it as more and more patients live from having finally gained access to L and Direct. Best wishes.
👍 1 💯 1
dennisdave dennisdave 10 minutes ago
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=175470267
👍️0
dennisdave dennisdave 10 minutes ago
I clearly said notice you made it into motion, and yes the defendant can respond to a plaintiff's Notice of Supplemental Authority filed in support of the plaintiff's opposition to the defendant's motion to dismiss. Such notices are typically submitted to inform the court of new legal developments or authorities that may impact the case. While not always required, responding to these notices allows the defendant to address the relevance and implications of the new authority presented

So that could, as I said mean more delay in the decision on the MTD
👍️0
manibiotech manibiotech 16 minutes ago
Lol
And no one cares about your nickel or dime that you are buying shares with as it is inconsequential to the MC or SP of the company and our ROI . 
Lol and you don't have to worry about anyone's existence . Worry about your own . 
👍️0
norisknorewards norisknorewards 22 minutes ago
you make no sense. what motion?
👍️0
flipper44 flipper44 23 minutes ago
It’s not a motion, it’s a notice. My guess is Defendants should have brought it to the Court’s attention as well, because it is directly on target and new, but obviously, they didn’t, because it does not help them in any way whatsoever. IMHO.
👍️ 2 💯 1
theorysuit theorysuit 23 minutes ago
Anything to keep hope alive...anything goes here. Here they pivot to Court case, reviving a failed product to distract from this train wreck of internal execution...lmfao.

You cant make this level of comedy up if you wanted to. Pump that hopium! Pump it.
👍️ 1 😇 1
dennisdave dennisdave 24 minutes ago
Im not arguing that the defendant has a strong case or could respond with something that would hold any sort of merit. Im saying that now this notion is filed the defendant has the right to respond with whatever suits them, which will delay the court decision we are all waiting for.
👍️0
flipper44 flipper44 26 minutes ago
Nice try at spin.
👍️0
learningcurve2020 learningcurve2020 28 minutes ago
Normal investors would see shelved Direct and zero revenue twenty year old L and call it a "Product failure"...But not here, of course. 
😾 1 ❌️ 1
flipper44 flipper44 30 minutes ago
What is there to respond to? It’s not a helpful decision for Market Makers. Why would they cite it? “Hey look Judge, here is a nonbinding decision that destroys our arguments.”
👍️ 1
dennisdave dennisdave 35 minutes ago
thats a great way to response by Posner
However timeline-wise now the Defendant will be granted the opportunity to respond which will cause more delay.
👍️0
flipper44 flipper44 38 minutes ago
Market Makers are writing their own damages epitaph, particularly with the adjective “product failures.” That little error (imho) could change M to B.
🏆️ 1 👍️ 2
evanstony evanstony 42 minutes ago
IMO the judge will shortly deny their Motion to Dismiss and the Market Makers will then need to settle the case ASAP.
I agree with statement... only roadblock that will need to be removed is the defendants attorney group that is making thousands per hour from all the MM's. After a few months of the humongous attorney bills the settlement will come.
👍️ 2
bas2020 bas2020 46 minutes ago
LOL. It's my own money that's buying all these shares. Sorry, not one nickel from anyone else.
Though, what a sad existence it must be to be paid to post lies every day. 👿☠️
It must take a natural-born liar to take such a job.
👍️ 2 💯 1
learningcurve2020 learningcurve2020 47 minutes ago
Still say the judge is waiting to see if NWBO is legit or not.  

>>See, e.g., Mot. to Dismiss at 3 ("...any [NWBO stock price] declines were not the result of fleeting alleged spoofing, but NWBO's corporate mismanagement, product failures, securities violations, and dilutive share issuances."); at 5 ("...declines in NWBO's stock price during the Relevant Period generally coincided with negative news about the company. NWBO also depressed its stock price throughout the Relevant Period by more than tripling the number of shares outstanding....")

👿 1 🚽 1 ☠️ 1
flipper44 flipper44 54 minutes ago
I’d guess it is simply a case notice of a new helpful authority. Magistrate Stein almost certainly already knew about it (the Phunware ruling) on November 27, 2024, and understood what it meant. I mean, defendants could admit they lost on their MTD, but I’d doubt they’ll do that. It’s hard to imagine it would slow down the magistrate, but because he is a magistrate, having his recommendations confirmed by two judges in the same circuit isn’t a bad thing.

Today is the Tuesday following Thanksgiving, and one day following Phunware’s Second Amended Complaint filing, so I’d suppose Ms. Posner was timely.

Artificial Intelligence quote below. (Note: I bet Magistrate Stein is probably considered a veteran legal scholar/technician within his circuit.)

In the same circuit, a "judge" typically has broader authority to hear and decide complex legal cases, while a "magistrate" has more limited jurisdiction, usually handling smaller matters like initial appearances in criminal cases, preliminary hearings, and certain civil disputes, often with the ability to refer more complex issues to a full judge for final decision.
👍 3
fluteman fluteman 57 minutes ago
Aggressive!
👍️0
learningcurve2020 learningcurve2020 60 minutes ago
Yeah, skull and crossbones / thumbs down.  If you're a legit shareholder that makes no sense whatsoever. 
👿 1 ☠️ 1
learningcurve2020 learningcurve2020 1 hour ago
Without a NICE mention yours is half an argument. 
👿 1 ☠️ 1
manibiotech manibiotech 1 hour ago
And from paid pumpers and apologists also mean nothing to me 
👿 1 ☠️ 1
Checkmate 36 Checkmate 36 1 hour ago
Ok Dud,
I’m glad your comrades have not put me on their ignore list…that way you have to see my posts. I know my posts bring you great joy. I try, I try…
👍️ 3 😅 2
XMaster2023 XMaster2023 1 hour ago
Some of the market makers will not want the publicity of beating up a cure for cancer. After approval, the propensity to settle will increase and there will be an internal struggle between the 7 Market Makers.
NONE of the market makers will want the trial to end up in front of a jury. The optics could not be worse as they would be lucky to walk out of the courtroom with a shirt on their back.
👍️ 8 💥 4
underpar71 underpar71 1 hour ago
I supposed this is good to have on the record and in support by case ruling. Does it delay a response by the Magistrate now? Or, just added to the files? And/or does this now add time for a response by defendants?
👍️0
ilovetech ilovetech 1 hour ago
Brainster - Thx. Our shareholder legal contributor over on X, suggested in his post dated Dec 2nd, that he anticipated a supplemental filing from Posner, as early as today in response to Judge Ho's recent ruling against the MTD in the Phunware case.
👍️ 8
flipper44 flipper44 1 hour ago
Posner Notice in Support…., filed December 3, 2024.

https://storage.courtlistener.com/recap/gov.uscourts.nysd.590344/gov.uscourts.nysd.590344.166.0.pdf
👍️ 10
RobotDroid RobotDroid 1 hour ago
Best to ignore whatever stalemate is saying. Fools and their money are always parted. He is forever on my esteemed ignore list.
👿 1 ☠️ 1
RobotDroid RobotDroid 1 hour ago
The court case is years away from any decision, and nwbo will have ceased to exist by then. It's just hopium.
👿 1 🚽 1 🚾 1 ☠️ 1
learningcurve2020 learningcurve2020 1 hour ago
Begs the question had the stock not nosedived on the one day of NYSA, would they still have initiated a lawsuit? 
👍️ 2 👿 1 ☠️ 1
learningcurve2020 learningcurve2020 1 hour ago
It's kind of outrageous that this two lawyer company doesn't provide an up to date webpage with all links dedicated to this alleged spoofing suit. 
👿 1 ☠️ 1
The Danish Dude The Danish Dude 1 hour ago
Yeah and remember all you fud lot to leave out of the equation, proven spoofing by 7 market makers since at least 2017, taken on by USAs best fraud lawyer in 2024. Forget the fraudulent lawsuits since 2014. The fraudulent complaints. The +40 hitpieces by AF. The extreme manipulation done by pawns on all stock boards. And not least the company of William F Doyle who we have proved have affiliated doctors - non disclosing interest - who've been trying to diss NWBO through manipulative articles, even while trying to front the helmet.

Ah yes lets not neither forget the considerable insider buying and selling of their piss stock right on time each time whether its after a pump, or when they prepare for it.

What a nice business setup.

How would it have been, if all these forces actually had supported a working treatment against cancer, instead of joining forces trying to bankrupt them?

But yes Scotty. Do what you lot do best.

Bury elementary basic knowledge, in order to still promote that crap narrative of yours.

At least you have quite an audience paid to agree with you in the open.

Its not everyone who will experience success trying to sell crazy.

By the way.

One dollar on the lady jockey over there.
👍️ 7 💥 4 💯 1 🚀 1
Investor082 Investor082 1 hour ago
Maybe you didn’t read the entire message.

You should be confident that LP has significant non dilutive funding lined up and that no one can take that fact away regardless of how anyone spins it. Are you worried that’s not the case? If not, you should ignore the noise and buy more shares.

Let me know your thoughts.
👍 1 👿 1 ☠️ 1
bas2020 bas2020 1 hour ago
Comments from paid cabal soldiers mean nothing to me.
👍️ 4 💯 4
norisknorewards norisknorewards 1 hour ago
hahahahahhaah....:"Nothing you or I say on this message board will have any impact on the share price"

so many saviors for the longs disagree and are here daily posting bs
👍️ 1
Investor082 Investor082 1 hour ago
Not sure why my opinions bother you. The future is in LP’s hands. Nothing you or I say on this message board will have any impact on the share price. You should be confident that LP has significant non dilutive funding lined up and that no one can take that fact away regardless of how anyone spins it. Are you worried that’s not the case? If not, you should ignore the noise and buy more shares.
👿 1 ☠️ 1
exwannabe exwannabe 2 hours ago
It is available now (as I used Recap to download it).

Just a letter from Posner noting the Phumware order and asserting it supports NWBO.
👍️ 1
mike00h mike00h 2 hours ago
Thank you, Branster
👍️ 1
Checkmate 36 Checkmate 36 2 hours ago
Keep that investment strategy/advice to yourself Investor082.

Are you a licensed financial advisor?
👍️ 2
manibiotech manibiotech 2 hours ago
Lol
No one is trying to shake your conviction . The discussion is about company and share price and execution and ROI.
You are self flattering and giving too much importance to yourself . As you can see in above sentence , none of it is about you , your holdings or your conviction . But you have convinced yourself somehow that world revolves around you . 
👿 1 🚽 1 ☠️ 1
manibiotech manibiotech 2 hours ago
Interesting 
👍️0
Investor082 Investor082 2 hours ago
Balanced perspective. I agree UK approval is pretty much a done deal. However, it’s what comes next (significant non dilutive funding) that will determine the long term direction of the share price. Otherwise we give up whatever gains we get at UK approval.

My bet is that LP will disappoint again. So UK approval may be the best chance to get out before significant dilution takes over again for the next couple of years.
👍️ 1 👿 1 ☠️ 1
branster branster 2 hours ago
Case 1:22-cv-10185-GHW-GS Document 166-1 Filed 12/03/24 Page 1 of 8
EXHIBIT A
Case 1:22-cv-10185-GHW-GS Document 166-1 Filed 12/03/24 Page 2 of 8
Case 1:23-cv-06426-DEH Document 34 Filed 11/26/24 Page 1 of 7
UNITED STATES DISTRICT COURT
SOUTHERN DISTRICT OF NEW YORK
PHUNWARE, INC.,
Plaintiff,
v.
UBS SECURITIES LLC,
Defendant.
DALE E. HO, United States District Judge:
23 Civ. 6426 (DEH)
OPINION AND ORDER
On April 23, 2024, this Court issued an Opinion and Order dismissing Plaintiff
Phunware, Inc.’s Complaint for failure to adequately plead loss causation. See Opinion and
Order (“Order”) at 13-16, ECF No. 30. The parties’ familiarity with the facts and allegations in
this matter is assumed. Now before the Court is Plaintiff’s motion for leave to file an amended
complaint. See Pl.’s Apr. 17, 2024 Letter Mot. (“Pl.’s Mot.”), ECF No. 31. For the reasons
stated below, Plaintiff’s motion is GRANTED.
LEGAL STANDARDS
Under Rule 15(a),1 leave to amend should generally be “freely given when justice so
requires.” Fed. R. Civ. P. 15(a)(2). This is particularly true where, as here, the district court has
granted a defendant’s motion to dismiss. See, e.g., Ronzani v. Sanofi S.A., 899 F.2d 195, 198 (2d
Cir. 1990) (“When a motion to dismiss is granted, the usual practice is to grant leave to amend
the complaint.”). A court’s refusal to grant leave to amend must be based on a valid ground, such
as where there is “evidence of undue delay, bad faith, [or] undue prejudice to the non-movant.”
Milanese v. Rust-Oleum Corp., 244 F.3d 104, 110 (2d Cir. 2001); see also Forman v. Davis, 371
1All references to Rules are to the Federal Rules of Civil Procedure. In all quotations from
cases, the Court omits citations, footnotes, emphases, internal quotation marks, brackets, and
ellipses, unless otherwise indicated.
Case 1:23-cv-06426-DEH Document 34 Filed 11/26/24 Page 2 of 7
Case 1:22-cv-10185-GHW-GS Document 166-1 Filed 12/03/24 Page 3 of 8
U.S. 178, 182 (1962). A court may also deny leave “in cases of futility of amendment,” Meyer v.
Seidel, 89 F.4th 117, 140 (2d Cir. 2023), meaning that the proposed amended complaint “fails to
cure prior deficiencies . . . [and] does not contain enough factual allegations, accepted as true, to
state a claim for relief that is plausible on its face.” Dobryakov v. Brickhouse Food LLC, No. 22
Civ. 1390, 2024 WL 218441, at *3 (S.D.N.Y. Jan. 19, 2024).
APPLICATION
Plaintiff alleges that Defendant UBS Securities, LLC engaged in “spoofing” of
Plaintiff’s stock, a practice in which a market participant first places numerous false orders to
artificially inflate or depress a security’s price, then takes advantage of the impact to transact at
the affected price, and finally cancels the initial false orders. See Pl.’s Mot. Plaintiff’s spoofing
claims arise under Sections 9(a)(2) and 10(b) of the Securities Exchange Act of 1934 as well as
New York common law. See id. For all of Plaintiff’s causes of action, Plaintiff must adequately
plead: (1) a manipulative act, (2) facts to support a strong inference of scienter, and (3) loss
causation. See Order at 4-6; see also Noto v. 22nd Century Grp., Inc., 35 F.4th 95, 102 (2d Cir.
2022) (Section 10(b)); Sharette v. Credit Suisse Int’l, 127 F. Supp. 3d 60, 80 (S.D.N.Y. 2015)
(Section 9(a)); Greentech Rsch. LLC v. Wissman, 961 N.Y.S.2d 406, 407 (App. Div. 2013) (New
York common law). This Court dismissed Plaintiff’s Complaint because, though it adequately
pled a manipulative act and scienter, Plaintiff failed to adequately plead loss causation. See
Order at 6. Thus, the question currently before the Court is whether Plaintiff’s Proposed
Amended Complaint (“PAC”) sufficiently cures the deficiencies in Plaintiff’s loss causation
pleading.
At the outset, the Court notes that the Second Circuit has not decided whether loss
causation pleadings are evaluated under Rule 9(b) or 8(a). See Abramson v. Newlink Genetics
2
Case 1:23-cv-06426-DEH Document 34 Filed 11/26/24 Page 3 of 7
Case 1:22-cv-10185-GHW-GS Document 166-1 Filed 12/03/24 Page 4 of 8
Corp., 965 F.3d 165, 179 n.65 (2d Cir. 2020). If they are evaluated under Rule 9(b)’s
“heightened pleading standard,” id., “[t]he complaint must simply give Defendants some
indication of the actual loss suffered and of a plausible causal link between that loss and the
alleged misrepresentations,” Loreley Fin. (Jersey) No. 3 Ltd. v. Wells Fargo Secs., LLC, 797 F.3d
160, 187 (2d Cir. 2015). If Rule 9(b)’s “heightened pleading standard” does not apply, Plaintiff’s
allegations must meet the standard articulated in Rule 8(a)(2), which requires only “a short and
plain statement of the claim showing that the pleader is entitled to relief.” See, e.g., Gru v.
Axsome Therapeutics, Inc., No. 22 Civ. 3925, 2023 WL 6214581, at *4 (S.D.N.Y. Sept. 25,
2023). Ultimately, the applicable pleading standard is not dispositive here, because Plaintiff
pleads with enough specificity to satisfy the more rigorous Rule 9(b) standard.
In Gamma Traders, the Second Circuit recognized two ways to plead loss causation in a
spoofing case. Gamma Traders - I LLC v. Merrill Lynch Commodities, Inc., 41 F.4th 71, 80 (2d
Cir. 2022). Plaintiff may plead loss causation under (1) a temporal proximity theory, where “its
trades occurred so close in time to [Defendant’s] spoofing as to permit [the court] to infer as a
matter of common sense that the market prices were artificial when [Plaintiff] traded,” or (2) a
long-term price impact theory, where the market price takes a protracted period of time to “return
to a non-artificial level after a spoof,” justifying an inference of “price artificiality during the
time in which plaintiff was trading.” Id.; accord Nw. Biotherapeutics, Inc. v. Canaccord Genuity
LLC, No. 22 Civ. 10185, 2023 WL 9102400, at *29 (S.D.N.Y. Dec. 29, 2023), report and
recommendation adopted, 2024 WL 620648 (S.D.N.Y. Feb. 14, 2024). Defendant argues that
Plaintiff fails to sufficiently plead loss causation under either theory. Def.’s Apr. 26, 2024 Opp’n
Letter (“Def.’s Opp’n”), ECF No. 33. Plaintiff argues that it sufficiently pleads under both
3
Case 1:23-cv-06426-DEH Document 34 Filed 11/26/24 Page 4 of 7
Case 1:22-cv-10185-GHW-GS Document 166-1 Filed 12/03/24 Page 5 of 8
theories. Pl’s Mot. The Court concludes that Plaintiff has sufficiently alleged loss causation
under the temporal proximity theory.
Plaintiff pleads that on January 26, 2021, Plaintiff sold 36,157 shares of PHUN2 from
09:30:01.265 A.M. to 09:30:51.329 A.M., within seconds of Defendant’s alleged spoofing
activity, at prices ranging from $2.12 to $2.22 per share, a decline of 5% from the pre-spoofing
level of $2.14 per share. Proposed Am. Compl. ¶¶ 118, 139, ECF. No. 31-3. Among these sales,
Plaintiff specifically made one sale transaction at 09:30:01.265 A.M. less than one second from
Defendant’s spoofing activity; six executing sales at 09:30:04 A.M. within four seconds of
Defendant’s spoofing activity; seven executing sales at 09:30:06 A.M. within six seconds of
Defendant’s spoofing activity; and nine executing sales at 09:30:10 A.M. within ten seconds of
Defendant’s spoofing activity. PAC ¶ 118. Plaintiff further pleads that, on October 26, 2021,
three minutes after Defendant’s spoofing activity, Plaintiff sold 1200 shares of PHUN at $6.29
per share, a decline of 8.3% from the pre-spoof level. PAC ¶¶ 144-45.
Viewed in the light most favorable to Plaintiff, the instances of sales within seconds of
Defendant’s spoofing activity are sufficient to plead loss causation under the temporal proximity
theory using a common-sense inference. See Nw. Biotheraputics, Inc., 2023 WL 9102400, at *30
(holding that the 30 instances of trading within an hour of the spoofing activity were temporally
proximate enough to justify a common-sense inference that plaintiff’s stock sales occurred at an
artificially depressed price). In contrast to Gamma Traders, where the plaintiff was unable to
identify when it traded its stocks, here, Phunware states that it traded stocks within seconds of
the spoofing, supporting a common-sense inference of loss. Gamma Traders, 41 F.4th at 80-81.
2PHUN is Phunware, Inc.’s stock symbol on Nasdaq. See https://perma.cc/977Z-5W6R.
4
Case 1:23-cv-06426-DEH Document 34 Filed 11/26/24 Page 5 of 7
Case 1:22-cv-10185-GHW-GS Document 166-1 Filed 12/03/24 Page 6 of 8
Defendant argues that Plaintiff’s PAC does not contain sufficient factual allegations to
substantiate the claim that “the immediate price impact of the spoofing lasted long enough to
have impacted Plaintiff’s Same-Day Sales.” Def.’s Opp’n 2. However, “a factual pleading about
how long the effects of spoofing last” is not required here, because Plaintiff pleaded trades
within seconds of Defendant’s spoofing, which is enough to justify a common-sense inference of
artificial price decline. Gamma Traders, 41 F.4th at 80, see also Irrera v. Humpherys, 859 F.3d
196, 198 (2d Cir. 2017) (explaining that “[j]udges . . . rely on their ‘experience and common
sense’” in “draw[ing] the line between speculative allegations and those of sufficient plausibility
to survive a motion to dismiss” (quoting Ashcroft v. Iqbal, 556 U.S. 662, 679 (2009))).
Defendant also argues that Plaintiff has failed to plead loss causation as to any of its sales
because it fails to explain why Plaintiff’s share price declines are not caused by other events,
such as Plaintiff’s sale of its own shares on the same day. Def.’s Opp’n 4. In light of the
discussion above, however, this argument fails because “[t]he effects of spoofing pose questions
of fact,” and a plaintiff at this stage is only required to “allege some facts that support an
inference of actual injury.” Gamma Traders, 41 F.4th at 80. Defendant’s proposed alternative
explanations for PHUN’s share price decline poses a fact question, and a plaintiff need not
disprove alternative theories at this stage.
Defendant further argues that Plaintiff’s factual allegations are internally conflicting and
thus entitled to no weight because Plaintiff alleges the stock price to be “continually declining
yet trending up on the Same-Day sales,” and that Defendant was selling shares when the stock
price was artificially deflated. Def.’s Opp’n 3. However, Plaintiff pleads that Defendant’s
spoofing episodes caused “a price decline followed by a partial reversion that provided
Defendant an opportunity to profit from its purchases (including Executing Purchases) at
5
Case 1:23-cv-06426-DEH Document 34 Filed 11/26/24 Page 6 of 7
Case 1:22-cv-10185-GHW-GS Document 166-1 Filed 12/03/24 Page 7 of 8
depressed prices. Following the partial reversion, PHUN’s share price stabilized, but at a still
depressed level.” PAC ¶ 125. “In reviewing a decision to dismiss a complaint on Rule 9(b)
grounds, [the court] assume[s] the truth of plaintiffs’ allegations.” O’Brien v. Nat’l Prop.
Analysts Partners, 936 F.2d 674, 676-77 (2d Cir. 1991). Granted, “a court need not feel
constrained to accept as truth conflicting pleadings that make no sense, or that would render a
claim incoherent, or that are contradicted either by statements in the complaint itself or by
documents upon which its pleadings rely, or by facts of which the court may take judicial
notice.” In re Livent, Inc. Noteholders Secs. Litig., 151 F. Supp. 2d 371, 405-06 (S.D.N.Y. 2001).
However, Plaintiff’s partial rebound theory is based on plausible factual allegations, and the
Court’s ability to take notice of conflicting statements does not extend to resolving fact questions
against the Plaintiff at this stage. Plaintiff’s PAC sufficiently pleads loss causation.
Accordingly, because Plaintiff sufficiently pleads loss causation under the temporal
proximity theory, the Court concludes that leave to amend is proper. As this stage, however, the
Court finds it unnecessary to determine whether the Plaintiff sufficiently pleads long-term price
impact. The Court’s decision is therefore without prejudice to motions practice with respect to
any alleged injury under the long-term price impact theory (or any other issues not addressed in
this Opinion).
For the reasons stated above, Plaintiff’s motion for leave to amend is GRANTED.
Plaintiff shall file an Amended Complaint by December 2, 2024. Parties shall appear at an
initial pretrial conference with the Court on January 15, 2025, at 11:00 A.M. EST and shall file
a joint status letter and proposed Civil Case Management Plan by January 8, 2025. A Notice of
Initial Pretrial Conference containing details for joining the conference and directions for the
joint status letter shall issue separately.
6
Case 1:23-cv-06426-DEH Document 34 Filed 11/26/24 Page 7 of 7
Case 1:22-cv-10185-GHW-GS Document 166-1 Filed 12/03/24 Page 8 of 8
The Clerk of the Court is respectfully directed to terminate ECF No. 31.
Dated: November 26, 2024
New York, New York
DALE E. HO
United States District Judge
7
👍 2
branster branster 2 hours ago
Case 1:22-cv-10185-GHW-GS Document 166 Filed 12/03/24 Page 1 of 5
UNITED STATES DISTRICT COURT
SOUTHERN DISTRICT OF NEW YORK
NORTHWEST BIOTHERAPEUTICS, INC.,
Plaintiff, - against-
CANACCORD GENUITY LLC, CITADEL
SECURITIES LLC, G1 EXECUTION
SERVICES LLC, GTS SECURITIES LLC,
INSTINET LLC, LIME TRADING CORP.,
and VIRTU AMERICAS LLC.
Defendants.
Case No: 1:22-cv-10185-GHW-GS
PLAINTIFF’S NOTICE OF SUPPLEMENTAL AUTHORITY IN SUPPORT OF ITS
OPPOSITION TO DEFENDANTS’ MOTION TO DISMISS
THE SECOND AMENDED COMPLAINT
Plaintiff Northwest Biotherapeutics, Inc. (“NWBO” or “Plaintiff”) respectfully submits
this Notice of Supplemental Authority to bring to the Court’s attention the recent decision in
Phunware, Inc. v. UBS Securities LLC, Case No. 1:23-cv-06426-DEH, ECF No. 34 (S.D.N.Y.)
(Ho, J.) (“Opinion,” attached as Exhibit A) (“Phunware II”), which further supports denial of
Defendants’ Motion to Dismiss Second Amended Complaint (ECF No. 156) (“Motion to
Dismiss”).
In briefing their Motion to Dismiss, Defendants repeatedly referred to the allegations in
Phunware as “identical” (Mot. to Dismiss at 1 and 13), and a “mirror image of this case” (Mot. to
Dismiss at 2), urging this Court to follow Phunware’s “on-point precedent” regarding “materially
identical spoofing allegations.” (Reply Br., ECF No. 162 at 2.) At that time, while finding that the
plaintiff had adequately pled manipulative acts and scienter, Judge Ho had dismissed the
1
Case 1:22-cv-10185-GHW-GS Document 166 Filed 12/03/24 Page 2 of 5
Phunware original complaint on the same narrow ground of loss causation on which this Court
granted Defendants’ motion to dismiss the First Amended Complaint. Phunware then amended its
loss causation allegations in nearly identical fashion to how NWBO has amended its allegations
here. Compare Phunware Redlined Version of First Amended Complaint (ECF No. 31-1) at
¶¶ 117-164 with NWBO Second Amended Complaint (ECF No. 150) at ¶¶ 288-330. Judge Ho has
now ruled that the amended complaint in Phunware adequately alleges loss causation under
Gamma Traders– I LLC v. Merrill Lynch Commodities, Inc., 41 F.4th 71, 80 (2d Cir. 2022), and
expressly rejected the same arguments that Defendants raise in their Motion to Dismiss. This Court
should do the same.
First, in Phunware II, Judge Ho held that nearly identical allegations as alleged here were
sufficient to adequately plead loss causation under either the Rule 8 or Rule 9(b) standard. See
Opinion at 2-3 (“At the outset, the Court notes that the Second Circuit has not decided whether
loss causation pleadings are evaluated under Rule 9(b) or 8(a)….Ultimately, the applicable
pleading standard is not dispositive here, because Plaintiff pleads with enough specificity to satisfy
the more rigorous Rule 9(b) standard.”)
Second, in Phunware II, Judge Ho held that the amended complaint sufficiently alleged
loss causation under the temporal proximity theory of Gamma Traders by pleading examples in
which the plaintiff sold its shares shortly after defendant’s spoofing, citing for support this Court’s
opinion that sales within one hour would be “temporally proximate enough to justify” the
“common-sense inference” that the plaintiff’s sales occurred at artificially depressed prices.
Opinion at 4 (citing Nw. Biotherapeutics, Inc. v. Canaccord Genuity LLC, No. 22 Civ. 10185, 2023
WL 9102400, at *30 (S.D.N.Y. Dec. 29, 2023), report and recommendation adopted, 2024 WL 620648
(S.D.N.Y. Feb. 14, 2024)). In so doing, Phunware II directly rejected Defendants’ attempt to limit
Gamma Traders’ temporal proximity theory to trades that occur within seconds, or at most two
2
Case 1:22-cv-10185-GHW-GS Document 166 Filed 12/03/24 Page 3 of 5
minutes, after spoofing episodes. See, e.g., Mot. to Dismiss at 14; Reply Br. at 3 n.3.
Notably, because the Court found that Phunware had sufficiently alleged loss causation
under Gamma Traders’ temporal proximity test for at least some of its sales, the Court held that it
need not rule at the pleading stage on whether it had also sufficiently met Gamma Traders’ long
term price impact test for its other sales, leaving that issue for motion practice at a later stage of
the litigation. Order at 6 (“[B]ecause Plaintiff sufficiently pleads loss causation under the temporal
proximity theory, the Court concludes that leave to amend is proper. As this stage, however, the
Court finds it unnecessary to determine whether the Plaintiff sufficiently pleads long-term price
impact.”).1
Third, in Phunware II, Judge Ho rejected the argument – identical to the core argument
raised by Defendants here – that Phunware’s allegations somehow suffer a fatal contradiction by
alleging both that prices partially rebound following spoofing episodes and that the defendant’s
spoofing caused its losses.2 Judge Ho instead credited Phunware’s well-pleaded factual allegations
that the defendant’s spoofing caused “a price decline followed by a partial reversion that provided
Defendant an opportunity to profit from its purchases (including Executing Purchases) at
depressed prices” and that “[f]ollowing the partial reversion, PHUN’s share price stabilized, but
at a still depressed level.” Opinion at 5-6 (“…Plaintiff’s partial rebound theory is based on
plausible factual allegations, and the Court’s ability to take notice of conflicting statements does
not extend to resolving fact questions against the Plaintiff at this stage.”) Nearly identical
1Like here, in Phunware, the plaintiff alleged that certain sales occurred in close temporal proximity to the defendant’s
spoofing (See, e.g., Phunware First Amended Complaint, ECF No. 35 at ¶¶ 118-119, 124-125, 138-162), and that
other sales were impacted by the long-term impact of defendants’ spoofing (See, e.g., id. at ¶¶ 120-122, 126-137).
2See, e.g., Mot. to Dismiss at 1 (“Indeed, just weeks ago, District Judge Dale E. Ho dismissed identical claims in
Phunware … holding that the very allegations of rapid price reversion that permitted a finding of scienter foreclosed
plaintiff’s attempt to plead loss causation.”); at 2 (“As in Phunware, NWBO’s own price reversion allegations are
fatal to its attempt to plead loss causation under Gamma Traders.”); at 4 (“Faced with the same paradox, Judge Ho
rightly dismissed the complaint in Phunware.”).
3
Case 1:22-cv-10185-GHW-GS Document 166 Filed 12/03/24 Page 4 of 5
allegations regarding the partial reversion of NWBO share prices following Defendants’ spoofing
are made here. See, e.g., ¶ 312 (“Following the partial reversion, NWBO’s share price stabilized,
but at a still depressed level.”); ¶ 321 (“The placement of non-marketable buy orders after the
completion of a Spoofing Episode induced only a partial price reversion that did not fully unwind
the impact of Defendants’ manipulative spoofing. Therefore, prices of NWBO stock did not fully
revert to the market level, even though these partial price reversions provided Defendants an
opportunity to profit from buying additional NWBO shares.”)
Finally, in Phunware II, Judge Ho rejected the defendant’s argument – similar to
Defendants’ argument here3 – that the amended complaint failed to rule out other possible causes
for the plaintiff’s stock price declines because, under Gamma Traders, “the effects of spoofing
pose questions of fact and a plaintiff at this stage is only required to allege some facts that support
an inference of actual injury” and “a plaintiff need not disprove alternate theories at this stage.”
Opinion at 5 (internal quotations omitted).
Accordingly, Judge Ho’s decision in Phunware II further demonstrates why Defendants’
Motion to Dismiss should be denied.
3See, e.g., Mot. to Dismiss at 3 (“…any [NWBO stock price] declines were not the result of fleeting alleged spoofing,
but NWBO’s corporate mismanagement, product failures, securities violations, and dilutive share issuances.”); at 5
(“…declines in NWBO’s stock price during the Relevant Period generally coincided with negative news about the
company. NWBO also depressed its stock price throughout the Relevant Period by more than tripling the number of
shares outstanding….”)
4
Case 1:22-cv-10185-GHW-GS Document 166 Filed 12/03/24 Page 5 of 5
Dated: December 3, 2024
New York, New York
Respectfully submitted,
By: Laura H. Posner
Laura H. Posner
Michael B. Eisenkraft
COHEN MILSTEIN SELLERS & TOLL PLLC
88 Pine Street, 14th Floor
New York, New York 10005
Tel: (212) 838-7797
Fax: (212) 838-7745
lposner@cohenmilstein.com
meisenkraft@cohenmilstein.com
Raymond M. Sarola
COHEN MILSTEIN SELLERS & TOLL PLLC
Two Logan Square
100-120 N. 18th Street, Suite 1820
Philadelphia, PA 19103
Tel: (267) 479-5700
Fax: (267) 479-5701
rsarola@cohenmilstein.com
Counsel for Plaintiff
5
👍 1 👍️ 4
Checkmate 36 Checkmate 36 2 hours ago
Bas,
Love it sir!
As Darth Vader would say: “the force is strong with this one.”

Let’s Go NWBO
#Cancersux
🎯 1 👍️ 1
mike00h mike00h 2 hours ago
There is a new notice, paywalled, concerning the lawsuit.
https://www.courtlistener.com/docket/66579590/northwest-biotherapeutics-inc-v-canaccord-genuity-llc/

Has anyone read it?
👍️0
Checkmate 36 Checkmate 36 2 hours ago
Sarcasm is Anger’s ugly cousin Scotty.

As Glad’s trash bag commercial quotes “Don’t get mad, get glad!”

BTW, the trash here on the board will head to the landfill within a month or so. So hand tight, be encouraged, and get Glad sir!
👍️ 2 💥 1 😄 2
dstock07734 dstock07734 2 hours ago
Good for you, bas2020.

Congrats on accumulating at such insanely low price. I assume this one you can hold for very long time and no need to invest in any others.
👍️ 3

Your Recent History

Delayed Upgrade Clock